NCT04531631
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- The Chinese University of Hong Kong Hong Kong
Clinical trial condition
Diabetes Mellitus, Type 2
Explore clinical trials studying Diabetes Mellitus, Type 2. Study availability and eligibility vary by location and protocol.
8,024 public trials
710 recruiting studies
Diabetes Mellitus, Type 2 trial results
NCT00659711
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
- Locations
-
- 115 Flint Road Buffalo, New York, United States
Completed
A Trial Investigating the Cardiovascular Safety of Oral Semaglutide in Subjects With Type 2 Diabetes
NCT02692716
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Novo Nordisk Investigational Site Little Rock, Arkansas, United States
- Novo Nordisk Investigational Site Searcy, Arkansas, United States
- Novo Nordisk Investigational Site Concord, California, United States
- Novo Nordisk Investigational Site Huntington Beach, California, United States
NCT04236206
- Conditions
- Behavior, Diabetes Mellitus, Diabetes Mellitus, Type 2, +9 more
- Locations
-
- Family Health Centers Alexandria, Egypt
NCT02849080
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Novo Nordisk Investigational Site Glendale, Arizona, United States
- Novo Nordisk Investigational Site Phoenix, Arizona, United States
- Novo Nordisk Investigational Site Lancaster, California, United States
- Novo Nordisk Investigational Site West Hills, California, United States
Completed
Study of the Genome, Gut Metagenome and Lifestyle of Patients With Incident Type 2 Diabetes Mellitus
NCT04113239
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Disease Attributes, +10 more
- Locations
-
- City Clinical Hospital V.P. Demikhova Moscow, Russia
NCT02607865
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Novo Nordisk Investigational Site Anniston, Alabama, United States
- Novo Nordisk Investigational Site Birmingham, Alabama, United States
- Novo Nordisk Investigational Site Tuscumbia, Alabama, United States
- Novo Nordisk Investigational Site Glendale, Arizona, United States
NCT02863419
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Novo Nordisk Investigational Site Birmingham, Alabama, United States
- Novo Nordisk Investigational Site Los Alamitos, California, United States
- Novo Nordisk Investigational Site San Diego, California, United States
- Novo Nordisk Investigational Site Denver, Colorado, United States
NCT02863328
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Novo Nordisk Investigational Site Tuscumbia, Alabama, United States
- Novo Nordisk Investigational Site Encino, California, United States
- Novo Nordisk Investigational Site La Mesa, California, United States
- Novo Nordisk Investigational Site Northridge, California, United States
NCT02906930
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Novo Nordisk Investigational Site Lancaster, California, United States
- Novo Nordisk Investigational Site Los Angeles, California, United States
- Novo Nordisk Investigational Site Montclair, California, United States
- Novo Nordisk Investigational Site North Hollywood, California, United States